AbbVie Inc. (ABBV) technical analysis

From the Sep 26, 2026 report · Read the full report

$266.28

+19.32% Sep 28, 2026

Indicators

Data as of Sep 28, 2026

Trend: Uptrend (price above the 50-day average, which is above the 200-day)

20-day average: $260.62
50-day average: $257.28
200-day average: $230.78
14-day RSI: 61.5; neutral
MACD (12/26/9): 2.69; above the signal (bullish momentum)
Signal line: 2.38; Histogram: 0.32

50-day average above the 200-day (golden cross)

Support and resistance

Relevant lows and highs of the last 6 months, computed from daily prices.

Resistance

Support

$264.26
$246.77

Performance

1M: +3.1%
3M: +4.7%
6M: +27.2%
1Y: +21.8%

From the Sep 26, 2026 report

As of 2026-09-25, ABBV is trading at $264.34, 8.2% above the 50-day SMA ($257.05) and 15.5% above the 200-day SMA ($228.40), confirming a robust medium-to-long-term uptrend. The RSI at 58.58 is neutral, indicating no overbought conditions, while the price remains well below the upper Bollinger Band ($269.91) at $5.57 below. Technical indicators including MACD (+2.64) and MACDH (+0.30) confirm bullish momentum without reversal signals. The current price position supports a sustainable uptrend with clear support levels and moderate volatility (ATR $5.22).

Frequently asked questions

What is the ABBV trend?

Uptrend (price above the 50-day average, which is above the 200-day)

Is ABBV overbought?

The 14-day RSI of ABBV is 61.5 (neutral) as of Sep 28, 2026.

Sources: Yahoo Finance (prices, financial statements and analysts' estimates) and the U.S. Treasury (10-year yield). Indicators and valuation are computed without AI.

AI-generated informational content. Not financial advice or a personalised investment recommendation. Investing involves risk, including loss of capital.

Every week, in your inbox

Rating changes, the highest-conviction stocks and the week's best research. Free.